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Introduction {#sec1}
============

The thymus is the primary lymphoid organ for generating T cells, a process that is regulated through the interaction of endogenous molecules with thymocytes (e.g., Notch and T cell receptor \[TCR\]) and stromal cells (e.g., Delta ligand and self-peptides on major histocompatibility complex \[MHC\]) ([@bib13]; [@bib38]). Initially, thymocytes lack cell surface expression of both CD4 and CD8 (i.e., double-negative \[DN\] cells) and develop from stage DN1 to DN4 as TCR expression increases due to the interaction between Notch on thymocytes and Delta ligand on thymic stromal cells ([@bib38]). The strength of the TCR signal from the MHC on thymic stromal cells with Delta-Notch interaction drives the transition to CD4^+^CD8^+^ double-positive (DP) thymocytes ([@bib13]; [@bib38]). Moreover, transforming growth factor (TGF)-β superfamily members, including TGF-β1, and Activin A from thymic stromal cells arrest the development of thymocytes by preventing their progression from the DN to the DP stage ([@bib23]; [@bib38]) and induce the apoptosis of DP thymocytes ([@bib37]). Furthermore, a strong TCR signal and high TGF-β superfamily activity during the DN stage accelerate the development or maturation of γδ thymocytes ([@bib13]; [@bib43]).

T cells have metabolic heterogeneity in regard to their various functions and development stages ([@bib1]; [@bib3]). Indeed, naive T cells are relatively dependent on bioenergetic catabolism, using oxidative phosphorylation and fatty acid oxidation for homeostatic maintenance ([@bib1]; [@bib3]). In contrast, to meet metabolic demands, activated and proliferating T cells generally depend on anabolism characterized by high mechanistic target of rapamycin (mTOR) activity and fatty acid synthesis and catabolism through glycolysis and amino acid metabolism ([@bib1]; [@bib3]). Recently, it was reported that the homeostatic production of thymocytes was regulated through the metabolic states of mTOR in both thymocytes ([@bib45]) and thymic stromal cells ([@bib40]).

Accumulating evidence suggests that nutritional factors are other key regulators of T cell development and differentiation. Indeed, malnutrition induces thymic involution ([@bib33]), and several nutrients, including zinc and vitamin A, are necessary for the maintenance of thymus ([@bib6]). Regarding vitamin A, retinoic acid signaling in thymic epithelial cells (TEC) is required to maintain an appropriate developmental balance from medullary (m) TEC to cortical (c) TEC and thus support thymocyte development ([@bib41]).

Vitamin B1 (thiamine) is an essential nutrient for the central metabolism rooted in pyruvate, branched amino acids, and ribose 5-phosphate as well as the citric acid cycle ([@bib7]). We previously reported that naive B cells in Peyer patches rely metabolically on the citric acid cycle, which has a high requirement for vitamin B1, to produce ATP for energy ([@bib20]). In contrast, IgA-producing plasma cells in the intestinal lamina propria utilize the glycolytic pathway for ATP production and thus have a decreased requirement for vitamin B1 ([@bib20]). Indeed, mice maintained on a vitamin B1-deficient diet showed significant reduction of naive B cells in Peyer patches without remarkable changes in IgA-producing plasma cells in the intestinal lamina propria ([@bib20]). Given that Peyer patches are the site in naive B cells for the class switching of IgM to IgA, especially to intestinal antigens, maintaining mice on a vitamin B1-deficient diet resulted in impaired intestinal IgA responses against orally immunized vaccine antigens ([@bib20]).

In the current study, we explored the immunologic roles of vitamin B1 in T cell development in thymus and found that vitamin B1 was highly required for appropriate production of TGF-β superfamily members from thymic stromal cells. This process was controlled through the metabolism of branched-chain amino acids.

Results {#sec2}
=======

Vitamin B1 Supports the Homeostatic Development of T Cells in the Thymus {#sec2.1}
------------------------------------------------------------------------

First, we evaluated whether dietary vitamin B1 affects T cell development in the thymus. Macroscopic analysis revealed that mice maintained on vitamin B1-deficient chow demonstrated remarkable decreases in the volume and weight of thymus and the total number of thymus cells, namely, thymic involution, compared with mice maintained on control chow ([Figures 1](#fig1){ref-type="fig"}A and 1B). Accordingly, the amount of vitamin B1 in thymus gradually decreased during the 3 weeks after dietary vitamin B1 was discontinued ([Figure 1](#fig1){ref-type="fig"}C). Flow cytometric analysis indicated that the proportion of DP thymocytes was decreased preferentially ([Figure 1](#fig1){ref-type="fig"}D). In contrast, vitamin B1 deficiency did not affect the overall proportion of TCRγδ^+^ cells among DN thymocytes ([Figure 1](#fig1){ref-type="fig"}E), but the proportion of cells that transitioned from immature, CD44^--^CD24^+^ cells to the mature, CD44^+^CD24^--^ subset of TCRγδ^+^ DN thymocytes was increased ([Figure 1](#fig1){ref-type="fig"}F).Figure 1Vitamin B1 Is Required to Inhibit Increases in Mature TCRγδ^+^ DN Thymocytes(A--F) (A) Macroscopic analysis of thymus on day 21, thymus weight; (B) total number of thymocytes at days 3, 7, 14, and 21 of feeding mice a vitamin B1-deficient diet (VB1--) or control diet (Con); and (C) thymic vitamin B1 concentration at days 3, 7, 14, and 21 of feeding mice a vitamin B1-deficient diet (VB1--) relative to control diet. FACS plots of (D) CD4 and CD8α on live thymocytes gated on 7-AAD^--^, (E) of TCRγδ^+^ cells among DN thymocytes, and (F) of CD44 and CD24 among DN-- TCRγδ^+^ thymocytes after 3 weeks of VB1-- or Con diet. Scale, 1 cm. Horizontal lines indicate median values. p values were obtained by using the Mann-Whitney *U*-test (∗p \< 0.05). The data shown are reproducible and are representative of two to five independent experiments.(G) The levels of *Runx3* mRNA in DN and DP thymocytes sorted from the VB1-- and Con groups are shown. Horizontal lines indicate median values. p values were obtained by using the Mann-Whitney *U*-test (∗p \< 0.05).

Given that increased expression of RUNX3 reportedly induces the maturation of DN TCRγδ^+^ thymocytes in thymus ([@bib43]), we assessed *Runx3* mRNA expression in DN thymocytes by using qRT-PCR analysis. *Runx3* mRNA expression levels in DN thymocytes were upregulated in vitamin B1-deficient mice compared with the control group ([Figure 1](#fig1){ref-type="fig"}G). These results suggest that vitamin B1 is required to control RUNX3 expression and thus maintain appropriate generation of DP and DN TCRγδ^+^ thymocytes.

High Requirement for Vitamin B1 in Thymic Stromal Cells {#sec2.2}
-------------------------------------------------------

We investigated whether vitamin B1 affects thymocytes directly. When purified DN thymocytes were co-cultured with the bone marrow-derived OP9--DL1 cell line as stromal cells, they developed to single-positive and DP thymocytes ([@bib21]). A similar pattern emerged when cultures were treated with oxythiamine, a vitamin B1 inhibitor ([Figure 2](#fig2){ref-type="fig"}A). Therefore, these results suggested that vitamin B1 inhibition did not directly affect thymocyte development *in vitro*, unlike *in vivo* vitamin B1 deficiency. Moreover, because we hypothesized that OP9--DL1 cells incubated with oxythiamine might not sufficiently recapitulate the *in vivo* thymic stromal environment in vitamin B1-deficient mice, we assessed the mRNA expression levels of thiamine transporter 1 (THTR1) ([@bib9]) in the OP9--DL1 cells and thymic stromal cells. Indeed, the levels of *Thtr1* mRNA were significantly higher in thymic stromal cells than in OP9--DL1 cells ([Figure S1](#mmc1){ref-type="supplementary-material"}). We then used immunohistochemistry to examine thiamine transporter 1 (THTR1) levels and showed that a population of EpCAM^+^ stromal cells expressed higher levels of THTR1 than did CD45^+^ thymocytes ([Figure 2](#fig2){ref-type="fig"}B). Given these findings, we then adopted a fetal thymic organ culture (FTOC) system to better mimic the thymic environment *in vivo*. Although treatment with oxythiamine did not significantly alter the proportion of DP thymocytes that developed from DN1--3 thymocytes ([Figure S2](#mmc1){ref-type="supplementary-material"}), the proportion of CD24^--^, mature DN TCRγδ^+^ thymocytes increased ([Figure 2](#fig2){ref-type="fig"}C). This result indicates that the thymic environment created by stromal cells requires vitamin B1 for the appropriate control of thymocyte development.Figure 2The Requirement for Vitamin B1 Is Higher in Thymic Stromal Cells Than in Thymocytes(A) FACS plots of developing thymocytes sorted from DN1--3 to DP are shown after incubation for 7 days in the presence of oxythiamine and OP9--DL1 cells.(B) Immunohistochemistry of murine thymus was performed by using monoclonal antibodies (mAbs) to either CD45 or EpCAM and THTR1. Scale bar, 100 μm. Merge area (yellow) was quantified as the color threshold of Merge (Y: 100, U: 0, and V: 120) and THTR1 (R: 100, G: 0, and B: 0) by using ImageJ.(C) FACS plots of CD24^--^ cells among DN TCRγδ^+^ thymocytes from sorted DN1--3 cells reconstituted in fetal thymic organ culture and incubated in the presence of oxythiamine. The data shown are reproducible and representative of five independent experiments.

Vitamin B1 Controls the Production of TGF-β Superfamily Members in Thymic Stromal Cells {#sec2.3}
---------------------------------------------------------------------------------------

Both TGF-βs and Activin A (also known as Inhba), which belongs to the TGF-β superfamily, reportedly block the developmental transition of thymocytes from the DN to DP stage ([@bib23]; [@bib39]) and induce the apoptosis of DP thymocytes ([@bib37]). Moreover, RUNX3 transcription is upregulated by TGF-β superfamily members through the phosphorylation of smad2 and smad3 ([@bib18]; [@bib31]). Prompted by these reports and our current findings, we evaluated the effect of vitamin B1 deficiency on the production of TGF-β superfamily members in thymic stromal cells. Compared with the control group, thymic stromal cells from the vitamin B1-deficient condition had increased levels of *Tgfb2*, *Gdf10*, and *Inhba* mRNA ([Figure 3](#fig3){ref-type="fig"}A); mRNA transcript levels did not differ between the control and vitamin B1-deficient groups for any other TGF-β superfamily member ([Figure S3](#mmc1){ref-type="supplementary-material"}). In addition, flow cytometric analysis consistently demonstrated that vitamin B1 deficiency increased the proportion of TCRγδ^+^ thymocytes expressing phosphorylated smad2 and smad3; these signaling molecules are induced by the TGF-β superfamily ([Figure 3](#fig3){ref-type="fig"}B). These results suggest that vitamin B1 modulates the expression of *Tgfb2*, *Gdf10*, and *Inhba* in thymic stromal cells, thus maintaining the homeostatic generation of DP and TCRγδ^+^ thymocytes through the phosphorylation of smad2 and smad3.Figure 3Thymic Stromal Cells Require Vitamin B1 to Inhibit Excessive Production of the TGF-β Superfamily *In Vivo*(A) The levels of *Gdf10*, *Inhba*, and *Tgfb2* mRNAs in thymic stromal cells after 3 weeks of feeding mice a vitamin B1-deficient diet (VB1--) or control diet (Con). Horizontal lines indicate median values. p values were obtained by using the Mann-Whitney *U*-test (∗p \< 0.05). The data shown are reproducible and representative of two independent experiments.(B) FACS plots showing the ratios of cells positive for phosphorylated smad2, smad3^+^, and CD8α^+^ among TCRγδ^+^ thymocytes from VB1-- and Con mice. Horizontal lines indicate median values. p values were obtained by using the Mann-Whitney *U*-test (∗p \< 0.05).

Vitamin B1 Promotes the Metabolism of Branched-Chain α-Keto Acids in Thymic Stromal Cells {#sec2.4}
-----------------------------------------------------------------------------------------

Vitamin B1 is well known as a necessary coenzyme for catalyzing the conversion of pyruvate to acetyl-CoA, of α-ketoglutarate to succinyl-CoA, of branched-chain α-keto acids (BCKAs) to branched-chain acyl-CoA, and of ribose 5-phosphate to glyceraldehyde 3-phosphate ([@bib24]; [@bib42]). Therefore, we wondered what metabolic changes might occur in thymic stromal cells. Metabolomic analysis using ion chromatography with Fourier transform mass spectrometry (IC-MS) showed that ketoleucine and ketoisoleucine, which are BCKAs that are generated as intermediate metabolites from branched-chain amino acids (BCAAs), were increased in the supernatant of thymic stromal cells that had been treated with oxythiamine; however, metabolites associated with the citric acid cycle and glycolysis remained unchanged ([Figures 4](#fig4){ref-type="fig"} and [S4](#mmc1){ref-type="supplementary-material"}).Figure 4Vitamin B1 Is Required for Appropriate Metabolism of Branched-Chain α-Keto Acids in Thymic Stroma *In Vitro*We used IC-MS to analyze citric-acid cycle metabolites in supernatants from murine thymic stromal cells that had been incubated with oxythiamine (Oxy) for 24 or 48 h. Horizontal lines indicate median values. Con, no-treatment control. ∗p \< 0.05 (Mann-Whitney *U*-test).

BCKAs Induced Excessive Production of TGF-β Superfamily Members {#sec2.5}
---------------------------------------------------------------

We investigated whether the BCKAs that accumulated in thymic stromal cells due to vitamin B1 insufficiency could increase the quantities of mRNAs encoding TGF-β superfamily members. Culturing thymic stromal cells in media containing ketoleucine and ketoisoleucine increased the mRNA expression of *Inhba*, *Tgfb2*, and *Gdf10* ([Figures 5](#fig5){ref-type="fig"} and [S5](#mmc1){ref-type="supplementary-material"}). These results suggest that vitamin B1-mediated metabolism of BCAAs, especially BCKAs, controls the production of TGF-β superfamily members in thymic stromal cells.Figure 5Branched-Chain α-Keto Acids Induce Excessive Production of the TGF-β Superfamily in Thymic Stromal CellsMurine thymic stromal cells were incubated for 48 h with either ketoleucine or ketoisoleucine, which are branched-chain α-keto acids. The levels of *Gdf10*, *Inhba*, and *Tgfb2* mRNAs in the thymic stromal cells were determined by using qRT-PCR. p values were obtained by using the two-tailed unpaired Student\'s *t* test (∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p \< 0.001). The data shown are reproducible and representative of two independent experiments.

Activin A, TGF-β, and GDF10 act as ligands for the TGF-β superfamily receptors ALK4 and ActRIIA (to Activin A and GDF10), ALK5 (to TGF-β), and others ([@bib11]), whereas K02288 inhibits various TGF-β superfamily receptors (e.g., ALK2, ALK1, ALK6, ALK3, ActRIIA, ALK4, and ALK5) ([@bib32]). These activities allowed us to use FTOC to evaluate the effect of K02288 on the oxythiamine-induced maturation of DN γδ thymocytes. Treatment with K02288 canceled the oxythiamine-induced excessive maturation of DN γδ thymocytes in FTOCs ([Figure 6](#fig6){ref-type="fig"}). These results suggest that impaired thymocyte differentiation in the vitamin B1-deficient condition was mediated by TGF-β superfamily members.Figure 6Vitamin B1 Inhibition Induces Excessive Maturation of γδ Thymocytes through TGF-β Superfamily Signaling in Fetal Thymic Organ CulturesFACS plot of CD24^--^ TCRγδ^+^ cells among DN developing thymocytes from sorted DN1--3 cells reconstituted in fetal thymic organ cultures incubated in the presence of oxythiamine, the TGF-β superfamily inhibitor K02288, or both agents. Horizontal lines indicate median values. p values were obtained by using the Mann-Whitney *U*-test (∗∗∗p \< 0.001, ∗∗p \< 0.01). The data shown are pooled from three independent experiments, which yielded reproducible data.

Changes in Peripheral T Lymphocytes {#sec2.6}
-----------------------------------

We next investigated the effect of vitamin B1 deficiency on the number of peripheral T lymphocytes in the gut, the site of numerous TCRγδ^+^ T lymphocytes, under immunologically naive conditions. Flow cytometric analysis revealed that vitamin B1 deficiency increased the proportion of CD8αα TCRγδ^+^ T lymphocytes in the small intestine ([Figure 7](#fig7){ref-type="fig"}A). A similar increase occurred in the CD8αα subpopulation of TCRβ^+^ T lymphocytes, an unconventional T lymphocyte subset derived from DN thymocytes ([@bib19]; [@bib30]) ([Figure 7](#fig7){ref-type="fig"}B), whereas vitamin B1 deficiency decreased the number of CD4 TCRβ^+^ T lymphocytes in the small intestine ([Figure 7](#fig7){ref-type="fig"}C). In addition, we found that the numbers of CD4 and CD8α IFN-γ^+^ TCRβ^+^ T lymphocytes, which are the main functional subsets in spleen ([@bib34]), were reduced in the spleens of vitamin B1-deficient mice ([Figure S7](#mmc1){ref-type="supplementary-material"}). These results suggest that vitamin B1 is required for the appropriate differentiation and function of T lymphocytes in peripheral tissues.Figure 7Vitamin B1 Suppresses the Excessive Production of Unconventional T Lymphocytes and Maintains Conventional CD4 T Lymphocytes in Small Intestine(A--C) The total number of (A) TCRγδ^+^, (B) CD8αα TCRβ^+^, and (C) CD4 TCRβ^+^ intestinal lymphocytes (i.e., lamina propria lymphocytes + intestinal epithelial lymphocytes) at 3 weeks after mice began a vitamin B1-deficient diet (VB1--) or control diet (Con). Horizontal lines indicate median values. p values were obtained by using the Mann-Whitney *U*-test (∗p \< 0.05). The data shown are pooled from three independent experiments, which yielded reproducible data.

Discussion {#sec3}
==========

Here we showed that vitamin B1 modulates the metabolism of BCKAs and consequent production of TGF-β superfamily members in thymic stromal cells; these activities are required to maintain the appropriate differentiation of DP and γδ thymocytes ([Figure 8](#fig8){ref-type="fig"}). These findings extend current knowledge by revealing the novel role of vitamin B1 as an essential micronutrient for homeostatic development of immune cells.Figure 8Hypothetical Scheme of the Mechanism Underlying Vitamin B1-Dependent Homeostatic Generation of Lymphocytes from Thymic Stromal CellsVitamin B1, which is transported through THTR1, is more highly required in thymic stromal cells than in thymocytes. Vitamin B1 suppresses overproduction of TGF-β superfamily members by promoting the metabolism of branched-chain α-keto acids in thymic stromal cells. Vitamin B1-dependent regulation of inappropriate TGF-β superfamily production (i) suppresses the apoptosis of DP thymocytes; (ii) protects against blockade of the DN to DP transition in thymocytes, which otherwise would cause spurious thymic involution; and (iii) prevents excess development of mature γδ thymocytes, leading to preferential differentiation of γδ lymphocytes.

Our current study showed that thymic stromal cells---but not CD45^+^ thymocytes---express THTR1 ([Figure 2](#fig2){ref-type="fig"}). Notably, THTR1 was not expressed in all thymic stromal cells ([Figure 2](#fig2){ref-type="fig"}B). In addition to cTEC and mTEC, recent studies using single-cell RNA sequencing have indicated that EpCAM^+^ thymic stromal cells comprise several functionally heterogeneous subsets, including tuft cells ([@bib2]; [@bib15]; [@bib25]). We found that some EpCAM^+^ thymic stromal cells preferentially express THTR1, to support appropriate development of thymocytes ([@bib38]).

Specificity protein 1 (Sp1) increases THTR1 in proximal tubular epithelial cells ([@bib22]), and p63 downregulates the activity of Sp1 in human nasal epithelial cells ([@bib17]). The expression level of p63 in TECs is negatively correlated with that of FoxN1, one of the main differential transcription factors in TECs ([@bib4]). Therefore, the THTR1 content of TECs might be orchestrated through FoxN1-induced downregulation of p63 and thus upregulation of Sp1. Furthermore, compared with other cTECs and mTECs, the MHC class II^high^ cTECs among EpCAM^+^ thymic stromal cells show greater expression of *FoxN1* mRNA ([@bib27]; [@bib28]); this result implies that FoxN1-initiated control of THTR1 expression might be upregulated in MHC class II^high^ cTECs.

We found that vitamin B1 insufficiency increased BCKA levels and the production of some TGF-β superfamily members, including *Inhba*, *Gdf10*, and *Tgfb2*, in thymic stromal cells ([Figures 3](#fig3){ref-type="fig"} and [5](#fig5){ref-type="fig"}). Ketoleucine increased intracellular Ca^2+^ levels in rat cerebral cortex *in vitro* ([@bib10]). Moreover, increased levels of intracellular Ca^2+^, which induces TGF-β in the 3T3TβRII cell line ([@bib44]), activated p38 MAPK and ERK1/2 in bone marrow macrophages *in vitro* ([@bib46]). Why *Inhba*, *Gdf10*, and *Tgfb2* mRNAs specifically are increased in thymic stromal cells remains unknown at this point. However, our current findings suggest that BCKAs, including ketoleucine and ketoisoleucine, may increase intracellular Ca^2+^ in thymic stromal cells, thus inducing MAPK- and ERK-mediated mRNA expression of TGF-β superfamily members, including *Inhba*, *Gdf10*, and *Tgfb2*.

We showed that dietary deficiency of vitamin B1 decreased the number of DP thymocytes and increased the numbers of mature γδ thymocytes in mice; these changes were associated with the increased expression of *Runx3* mRNA and the phosphorylation of smad2 and smad3 in thymocytes ([Figures 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}). In support of our current findings, previous studies showed that various TGF-β superfamily members, including Activin A, GDF10, and TGF-β2, induce the phosphorylation of Smad2 and Smad3 ([@bib11]) and upregulate the expression of RUNX3 ([@bib16]; [@bib31]) and that TGF-β2 induces the RUNX3-mediated maturation of γδ thymocytes ([@bib43]). In addition, TGF-β and Activin A block thymocyte progression from the DN stage to the DP stage and induce the apoptosis of DP thymocytes ([@bib23]; [@bib37]; [@bib39]).

Consistent with the *in vivo* results, treatment with oxythiamine increased the proportion of CD24^--^ mature DN γδ thymocytes ([Figure 2](#fig2){ref-type="fig"}C) but did not significantly alter the proportion of DP thymocytes that developed from DN1--3 thymocytes ([Figure S2](#mmc1){ref-type="supplementary-material"}). As an explanation of this apparent discrepancy, previous studies showed that fetal TECs had a greater rate of cell growth than those from adult thymus ([@bib5]) and that increased cell growth activity was associated with low dependency on BCAA catabolism in cardiomyocytes ([@bib36]). Thus, under vitamin B1-deficient conditions, BCKA accumulation likely was lower in FTOCs than in adult thymus. In support of this notion, exogenous addition of BCKAs reduced the proportion of DP thymocytes in FTOCs ([Figure S6](#mmc1){ref-type="supplementary-material"}). Furthermore, given that TGF-β receptors (i.e., Tgfβr1, Tgfβr2) were more highly expressed in TCRγδ^+^ thymocytes than in DP thymocytes ([@bib8]), DN γδ thymocytes might have greater sensitivity to the oxythiamine-induced production of BCKAs and TGF-β superfamily ligands.

In line with the immunologic phenotypes in the thymus, vitamin B1 deficiency decreased the population of DP thymocyte-derived CD4 TCRβ^+^ T lymphocytes in the gut ([Figure 6](#fig6){ref-type="fig"}). In contrast, we noted increases in the numbers of TCRγδ^+^ T lymphocytes and CD8αα TCRβ^+^ T lymphocytes ([Figure 6](#fig6){ref-type="fig"}), which developed from DN thymocytes through TGF-β-mediated RUNX3 expression ([@bib19]; [@bib30]). Moreover, we showed that vitamin B1 deficiency led to a decrease in IFN-γ^+^ TCRβ^+^ T lymphocytes ([Figure S7](#mmc1){ref-type="supplementary-material"}). Given that pyruvate dehydrogenase (PDH) induces the production of acetyl-CoA to induce the transcription of IFN-γ transcription ([@bib29]) and that vitamin B1 is an essential co-enzyme for PDH ([@bib20]), vitamin B1 deficiency plausibly impaired PDH activity and consequently inhibited IFN-γ production.

Together, our current findings indicate that vitamin B1 is required for the appropriate differentiation of thymocytes, especially the development of DN cells into DP or γδ thymocytes. This regulation is mediated through control of the production of TGF-β superfamily members including Activin A, GDF10, and TGF-β2; this regulation is achieved by promoting the metabolism of BCKAs in thymic stromal cells. These findings provide new evidence of vitamin B1-mediated interaction between stromal and immune cells for the appropriate development of thymocytes.

Limitations of the Study {#sec3.1}
------------------------

This study demonstrated that vitamin B1 was necessary for the appropriate metabolic functions in thymic stromal cells for the homeostatic differentiation of T cells. Although we proposed that a specific subset of thymic stromal cells expressing high levels of THTR1 were responsible for it, we could not specify them due to the experimental restriction of anti-THTR1 antibody.
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Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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